Pertussis Immunisation

7 drugs in development·1 company·3 clinical trials

Drug Pipeline by Phase

Phase 3(6)

Drug	Company
dtwp-hepb-hib pentavalent vaccine (diphtheria toxoid	Sanofi (SNY)
dtwp-hepb-hib-ipv hexavalent vaccine (diphtheria toxoid	Sanofi (SNY)
human rotavirus	Sanofi (SNY)
inactivated poliomyelitis vaccine	Sanofi (SNY)
pneumococcal polysaccharide conjugate vaccine (13-valent	Sanofi (SNY)
poliomyelitis vaccine bivalent types 1 and 3	Sanofi (SNY)

Phase 4(1)

Drug	Company
tetanus toxoid	Sanofi (SNY)

BioSniper tracks 7 drugs in development for Pertussis Immunisation across 1 company.

There are 3 clinical trials targeting Pertussis Immunisation tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.